HIGH-GRADE B-CELL LYMPHOMA, NOS
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA, NOS explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA, NOS trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA, NOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat lymphoma: three-drug combo enters early trials
Disease control Not yet recruitingThis early-phase trial tests whether combining three drugs (golcadomide, poseltinib, and rituximab) can shrink or control tumors in people with relapsed or refractory large B-cell lymphoma. About 20 adults will take part. The goal is to see if the combination works better than cu…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA, NOS
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 17, 2026 18:48 UTC
-
An open-label, phase i trial, with an expansion cohort: macrophage conditioning to synergize with CAR-T in high-risk lymphoma (MAC-SHIFT)
Not yet recruitingAxatilimab + CAR-T in High-Risk Lymphoma
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA, NOS
Phase: PHASE1 • Sponsor: Northside Hospital, Inc.
Last updated Jun 17, 2026 18:34 UTC